Elizabeth George, MD
Vascular Surgery · Palo Alto, CANPI 1598184715
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Medtronic at 54.3% of the total. Reporting peaked in 2021 at $3,125 and has fallen 69.5% since, to $954 in 2025.
Across 56 payments — averaging $106.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- W. L. Gore & Associates, Inc.$905
- Artivion, Inc.$394
- Boston Scientific$366
- Abbott$312
- Penumbra, Inc.$162
- plus $590 from 9 others
What the payments were for
- Grants$3,12552%
- Food & beverage$2,84948%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $3,245 |
| W. L. Gore & Associates, Inc. | 24 | $905 |
| Artivion, Inc. | 1 | $394 |
| Boston Scientific | 4 | $366 |
| Abbott | 3 | $312 |
| Penumbra, Inc. | 2 | $162 |
| Cagent Vascular Inc | 2 | $129 |
| Cook Medical LLC | 7 | $121 |
| Bard Peripheral Vascular, Inc. | 1 | $116 |
| Veryan Medical Incorporated | 1 | $94 |
| Silk Road Medical, Inc. | 1 | $52 |
| Philips North America LLC | 1 | $23 |
| Shockwave Medical, Inc | 1 | $22 |
| Mimedx Group, Inc. | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$3,125
- AMDS-Ascyrus Medical$394
- BIOGLUE SURGICAL ADHESIVE$394
- CRYOVALVE SG PULMONARY HUMAN HEART VALVE$394
- Perclose ProGlide suture mediated closure system$294
- Indigo System$146
- ENROUTE Transcarotid Neuroprotection System$145
- GENERAL VASCULAR INTERVENTION$144
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$141
- GORE TAG Conformable Thoracic Endoprosthesis$125
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$124
- Lutonix Drug Coated Balloon$116
- GORE TAG Thoracic Branch Endoprosthesis$108
How this compares
$5,974 in reported general payments places this provider in the 55th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $12,269 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Palo Alto
- Venita ChandraPalo Alto$488K
- Karthikeshwar KasirajanPalo Alto$349K
- Jason LeePalo Alto$228K
- Kenneth TranPalo Alto$65K
- Son DuongFountain Valley$503K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.